Keith Gibson

Associate

Weil, Gotshal & Manges LLP

Current

Current

GlaxoSmithKline Ferndale v. Block Drug Represented Block Drug (owned by GSK) against Ferndale who in a lower court decision was awarded $8.3 million in damages for breach of a contract between Block and Ferndale, and its co-defendant, Schwarz Parma, who was assessed damages of $2.1 million based on a finding of unjust enrichment. On appeal, WGM relied on a different damage theory and the calculations of another expert. The Sixth Circuit reduced the damage award against Block to $216,000 and threw out the award against our co-defendant, accepting completely WGM's damage theory and the calculations of WGM's expert, and directed the District Court to enter judgment based on those calculations. more

Duke University

J.D.

2002

Texas Tech University

1997

B.B.A.

Publication

Extending The Bounds Of Personal Jurisdiction In The Global Market Place (co-authored for program with Richard Rothman and Keith Gibson) (Washington, DC, November 06, 2002) Organization for International Investment General Counsel Conference (Washington DC 2002)